2002
DOI: 10.1016/s0360-3016(02)03138-3
|View full text |Cite
|
Sign up to set email alerts
|

Health-related quality of life (HRQOL) in men treated with prostate brachytherapy alone on radiation therapy oncology group (RTOG) trial 98-05

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2004
2004

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The Radiation Therapy Oncology Group ͑RTOG͒ recently completed a Phase I/II multiinstitutional trial examining I-125 prostate brachytherapy as the sole treatment for early stage prostate cancer. 38 This trial specified seed activity of approximately 0.4 mCi each. Therefore, based on the current and accepted practice of PPB, it does not seem as if the use of fewer high activity seeds is a practical solution to the problem posed by seed overlap described in this study.…”
Section: Discussionmentioning
confidence: 99%
“…The Radiation Therapy Oncology Group ͑RTOG͒ recently completed a Phase I/II multiinstitutional trial examining I-125 prostate brachytherapy as the sole treatment for early stage prostate cancer. 38 This trial specified seed activity of approximately 0.4 mCi each. Therefore, based on the current and accepted practice of PPB, it does not seem as if the use of fewer high activity seeds is a practical solution to the problem posed by seed overlap described in this study.…”
Section: Discussionmentioning
confidence: 99%